عرض بسيط للتسجيلة

المؤلفNashwan, A.J.
المؤلفYassin, M.A.
المؤلفSoliman, A.T.
المؤلفDe Sanctis, V.
المؤلفIbrahim, M.I.
تاريخ الإتاحة2023-09-18T09:52:24Z
تاريخ النشر2022
اسم المنشورActa Biomedica
المصدرScopus
معرّف المصادر الموحدhttp://dx.doi.org/10.23750/abm.v93i3.13103
معرّف المصادر الموحدhttp://hdl.handle.net/10576/47636
الملخصThe number of COVID-19 vaccine-rich countries that have started COVID-19 third-dose booster programs is growing dramatically despite the lack of robust evidence on the effectiveness, safety, and frequency of the required booster doses that make the individuals/populations immune to COVID-19 infection. Beyond the ethical dilemma, the scarcity of studies on the optimal timing for offering booster doses, eligibility criteria, and if there is any association between premature or delayed administration and the degree of protection against infection. The aim of this mini-review was to collect and analyze published data on this topic in a trial to answer some questions related to the benefits versus the risks of offering frequent boosters of mRNA vaccines for increasing the population immunity against COVID-19 infection considering the current policy of providing SARS-CoV-2 vaccine booster doses in rich countries versus those in relatively poor countries with limited access to vaccination. (www.actabiomedica.it).
اللغةen
الناشرMattioli1885
الموضوعVaccine Hesitancy
Measles
Anti-Vaccination Movement
العنوانmRNA-based COVID-19 Vaccines Booster Dose: BenefitRisks, and Coverage
النوعArticle
رقم العدد3
رقم المجلد93
dc.accessType Abstract Only


الملفات في هذه التسجيلة

الملفاتالحجمالصيغةالعرض

لا توجد ملفات لها صلة بهذه التسجيلة.

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة